PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34185201-5	2021	The other major area of exploration in the present review is based on the new targets for the modulation of fetuin-A, like calorie restriction and novel pharmacological agents, such as rosuvastatin, metformin, and pioglitazone which are successfully implicated in the management of various liver-related complications.	Pioglitazone	214-226	alpha 2-HS glycoprotein	Homo sapiens	108-116	
24551137-7	2014	In addition, GW 9662, an inhibitor of peroxisome proliferator-activated receptor (PPAR) gamma, reversed pioglitazone-induced suppression of fetuin-A, suggesting that thiazolidinedione derivatives may have common characteristics with regard to fetuin-A suppression, possibly through PPARgammaactivation.	Pioglitazone	104-116	alpha 2-HS glycoprotein	Homo sapiens	140-148	
30123261-0	2018	Low-Dose Spironolactone-Pioglitazone-Metformin Normalizes Circulating Fetuin-A Concentrations in Adolescent Girls with Polycystic Ovary Syndrome.	Pioglitazone	24-36	alpha 2-HS glycoprotein	Homo sapiens	70-78	
25450818-0	2015	Comparative effects of metformin and pioglitazone on fetuin-A and osteoprotegerin concentrations in patients with newly diagnosed diabetes: A randomized clinical trial.	Pioglitazone	37-49	alpha 2-HS glycoprotein	Homo sapiens	53-61	
25450818-7	2015	Pioglitazone resulted in a significant reduction in both fetuin-A and OPG in men, but only fetuin-A in women.	Pioglitazone	0-12	alpha 2-HS glycoprotein	Homo sapiens	57-65	
25450818-10	2015	In men, pioglitazone more effectively decreased fetuin-A levels in both uni- (p=0.011) and multivariate models (p=0.015) and OPG levels in only uni- (p=0.023) but not the multivariate model (p=0.547).	Pioglitazone	8-20	alpha 2-HS glycoprotein	Homo sapiens	48-56	
25450818-11	2015	CONCLUSIONS: Metformin and pioglitazone differentially affect fetuin-A and osteoprotegrin levels in diabetic women and men.	Pioglitazone	27-39	alpha 2-HS glycoprotein	Homo sapiens	62-70	
25468829-5	2015	Weight loss, aerobic exercise, metformin and pioglitazone have each been shown to be effective for reducing FetA level.	Pioglitazone	45-57	alpha 2-HS glycoprotein	Homo sapiens	108-112	
24551137-0	2014	Direct inhibitory effects of pioglitazone on hepatic fetuin-A expression.	Pioglitazone	29-41	alpha 2-HS glycoprotein	Homo sapiens	53-61	
24551137-3	2014	We previously reported that pioglitazone treatment significantly reduced serum fetuin-A levels in patients with type 2 diabetes.	Pioglitazone	28-40	alpha 2-HS glycoprotein	Homo sapiens	79-87	
32113823-8	2020	In the pioglitazone group, fetuin-A levels also decreased after 24 weeks (659.3+-111.8 vs. 538.1+- 101.0mug/mL, P<0.05) but not to the level of the liraglutide group.	Pioglitazone	7-19	alpha 2-HS glycoprotein	Homo sapiens	27-35	
26105582-8	2015	Fenofibrate, alone and in combination with pioglitazone, significantly decreased triacylglycerol, hs-CRP, IL-6, fetuin A and increased sirtuin 1 levels (P&lt;0.001) which suggests that it can be used to delay the complications of obesity and T2DM.	Pioglitazone	43-55	alpha 2-HS glycoprotein	Homo sapiens	112-120	
24551137-7	2014	In addition, GW 9662, an inhibitor of peroxisome proliferator-activated receptor (PPAR) gamma, reversed pioglitazone-induced suppression of fetuin-A, suggesting that thiazolidinedione derivatives may have common characteristics with regard to fetuin-A suppression, possibly through PPARgammaactivation.	Pioglitazone	104-116	alpha 2-HS glycoprotein	Homo sapiens	243-251	
24551137-9	2014	These findings suggest that pioglitazone may partially ameliorate insulin resistance through its direct inhibitory effects on fetuin-A expression in the liver.	Pioglitazone	28-40	alpha 2-HS glycoprotein	Homo sapiens	126-134	
18702951-0	2008	Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus.	Pioglitazone	11-23	alpha 2-HS glycoprotein	Homo sapiens	33-41	
18702951-6	2008	To address this, we investigated the effects of representative insulin-sensitizing therapies such as pioglitazone, metformin, and aerobic exercise on fetuin-A levels.	Pioglitazone	101-113	alpha 2-HS glycoprotein	Homo sapiens	150-158	
18702951-13	2008	We hypothesize that pioglitazone could partially ameliorate insulin resistance via modulating fetuin-A levels.	Pioglitazone	20-32	alpha 2-HS glycoprotein	Homo sapiens	94-102